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ABSTRACT 
Magnetotactic bacteria are aquatic prokaryotes that can move under the 
direction of a local geomagnetic field. The magnetosomes found in 
magnetotactic bacteria are arranged in a single chain or chains, which is the 
physics basis of magnetotaxis trait. It is believed that with the trait of 
magnetotaxis, magnetotactic bacteria can simplify their search for the optimal 
oxygen environments. 
Mms6 is a magnetosome membrane-associated protein in 
Magnetospirillum magneticum strain AMB-1. It has 59 amino acids with a 
hydrophobic N-terminal and a hydrophilic C-terminal region. Magnetite 
nanoparticles with similar size and shape to bacterial magnetite can be 
synthesized in vitro in the presence of recombinant Mms6.  
Our data demonstrated that Mms6 and its C-terminus forms complexes 
thus may provide the surface for magnetite nanoparticles formation. We 
examined the sizes and morphologies of magnetite nanoparticle synthesized 
in the presence of His-Mms6, GST-Mms6 and C25Mms6 by transmission 
electron microscopy. We used gel filtration and dynamic light scattering to 
investigated the multimeric states of the various versions of Mms6 we used. 
The results indicated that the multimeric forms of Mms6 may be required for 
the successful synthesis of uniform magnetite nanoparticles. A possible 
mechanism of Mms6 stimulated magnetite nanoparticle formation is proposed. 
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INTRODUCTION 
Magnetoreception is a sensory system that provides the orientation, 
navigation, and homing traits for some creatures from bacteria to higher 
vertebrates (Bertani, Weko et al. 2001). The physical basis of this response is 
thought to be the nanoparticles of single-domain magnetite (Diebel, Proksch et 
al. 2000). These nanoparticles have been found in fish, pigeons, honeybees, 
and even in human brains (Kirschvink, Kobayashi-Kirschvink et al. 1992; 
Diebel, Proksch et al. 2000; Bertani, Weko et al. 2001). It is believed that they 
are responsible for the direction-sensing behaviors of these organisms. The 
mechanisms regarding biomineralization remain unclear and are under 
intensive investigation. 
Lots of effort has focused on the synthesis and characterization of such 
magnetite nanoparticles (Michael Breulmann 1998; Valenti, Rampa et al. 1998; 
Mitsuhiro Okuda 2003). There has been an increasing interest in synthesizing 
magnetite nanoparticles using either inorganic approaches or biological 
systems (Meldrum, Heywood et al. 1992; Naka and Chujo 2001; Mitsuhiro 
Okuda 2003). Magnetite nanoparticles have been used for biotechnological 
and biomedical applications, because of their abilities to be magnetically 
controlled by applying an external magnetic field (Valenti, Rampa et al. 1998; 
Osaka, Matsunaga et al. 2006). Successful examples include cell separation  
(Kuhara, Takeyama et al. 2004), automated DNA extraction (Yoza, Arakaki et 
al. 2003) and magnetic resonance imaging (Pardoe, Clark et al. 2003; Lazaro, 
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Abadia et al. 2005; Trabesinger 2005). 
Magnetotactic Bacteria 
Magnetotactic Bacteria are aquatic prokaryotes that can move under the 
direction of a local geomagnetic field. They were first reported by R.P 
Blakemore (Blakemore 1975). The first strain of magnetotactic bacteria was 
found in marine sediments. These novel bacteria are featured with flagella, 
magnetite particles with defined uniform morphology and cytoplasmic 
membrane vesicles which were termed ‘magnetosomes’ (Blakemore 1975; 
Balkwill, Maratea et al. 1980). These bacteria can move in a magnetic field as 
weak as 0.5 gauss (Blakemore 1975; Blakemore, Maratea et al. 1979).  
After the discovery of the first magnetotactic bacterial strain, a series of 
magnetotactic bacterial strains have been reported from marine and fresh 
water  (Blakemore, Maratea et al. 1979; Frankel, Blakemore et al. 1979; 
Blakemore 1982). The cellular morphologies of magnetotactic bacteria vary 
from “cocoid, rod-shaped, helical to even multicellular” (Blakemore 1982; 
Bazylinski and Frankel 2004).  
Despite the diversity of cellular morphologies, magnetotactic bacteria 
share some common features: All magnetotactic bacteria reported to date are 
gram-negative bacteria. They have flagella and can move under the direction 
of the local geomagnetic field. They all have unique intracellular compartments, 
which are the magnetosomes. When moving, all magnetotactic bacteria have 
a migration preference for a low oxygen concentration environment (Bazylinski 
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and Frankel 2004). 
Magnetotactic bacteria discovered to date fall into three general categories: 
Obligate microaerophiles, anaerobes or both (Bazylinski and Frankel 2004). In 
an aqueous environment, they constitute a large portion of the bacterial 
population in the oxic-anoxic interface (Frankel, Bazylinski et al. 1997; 
Bazylinski and Frankel 2004). Magnetotactic bacteria are very sensitive to the 
environmental oxygen concentration and most of them can only synthesize 
magnetosomes in a very narrow range of low oxygen concentrations: 
Generally, if the initial oxygen concentration in the atmosphere of sealed 
cultures is higher than 6 %, these bacteria cannot synthesize magnetites  
(Blakemore, Maratea et al. 1979; Bazylinski and Frankel 2004). This fastidious 
growth requirement of magnetotactic bacteria has limited the progress in this 
research field for many years and the number of pure cultured strains is still 
very small (Bazylinski and Frankel 2004). 
Bacterial Magnetite Particles 
Definitive studies of the chemical composition of magnetite particles 
synthesized in magnetotactic bacteria had not been possible until the first pure 
culture of magnetotactic bacteria, Magnetotactic Spirillium strain MS-1, was 
isolated in 1979 by R.P.Blakemore et al. (Blakemore, Maratea et al. 1979). By 
using Mössbauer spectroscopy, Frankel et al. clearly demonstrated that the 
iron-containing mineral synthesized inside Magnetotactic Spirillium strain MS-1 
is ferromagnetic Fe3O4 with an average size (maximum dimension) of about 
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50nm (Frankel, Blakemore et al. 1979). The magnetite particles synthesized by 
magnetotactic bacteria have high chemical purity. This is the first direct 
evidence to demonstrate that the presence of magnetites in living organisms 
may participate in their responses to external magnetic fields (Frankel, 
Blakemore et al. 1979; Bazylinski and Frankel 2004).  
Magnetotactic bacteria usually synthesize ferricmagnetic magnetites 
(Fe3O4). But it has also been reported that in some magnetotactic bacteria,  
which were discovered in sulphide rich aqueous environments, the iron 
mineral crystals are present in the form of ferricmagnetic greigite (Fe3S4) 
(Farina, Esquivel et al. 1990; Mann, Sparks et al. 1990). The compositions of 
iron mineral crystals are strain specific and under strict chemical control by the 
bacteria (Bazylinski and Frankel 2004). Meldurm el al. demonstrated that two 
cultured magnetotactic bacterial strains, MC-1 and MV-2, which synthesize 
magnetites inside their magnetosome vesicles, continue to synthesize Fe3O4 
instead of Fe3S4 even when hydrogen sulphide was supplied in the culture 
medium (Meldrum, Mann et al. 1993; Meldrum, Mann et al. 1993). Only one 
magnetotactic bacterial strain has been reported that can synthesize both 
magnetite (Fe3O4) and greigite (Fe3S4), but a pure culture of this magnetotactic 
bacterium has not yet been isolated (Bazylizinki, Heywood et al. 1993; 
Bazylinski, Frankel et al. 1995; Bazylinski and Frankel 2004).  
Usually, the size of Fe3O4 or Fe3S4 synthesized by magnetotactic bacteria 
ranges from 35nm to 120nm but is consistent within each species or strain of 
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magnetotactic bacterium (Bazylinski, Garrattreed et al. 1994). The 
morphologies of the mineral crystals reported to date fall into three general 
categories: “roughly cuboidal; elongated prismatic (roughly rectangular); and 
tooth-, bullet- or arrowhead-shaped” (Bazylinski and Frankel 2004). 
Little is known about the real process and mechanism of magnetite particle 
synthesis inside magnetotactic bacteria. It has been proposed that it may 
involve three stages (Frankel, Papaefthymiou et al. 1983; Bazylinski, Frankel 
et al. 1995; Bazylinski and Frankel 2004): First, ferric ions are taken up by the 
cells through some specific iron transport systems and then reduced to ferrous 
ions and transported into the magnetosome vesicles where the magnetite 
particles are synthesized. Second, ferrous ions are reoxidized to ferric ions 
and form hydrous ferric oxides. The final stage is reducing one-third of the 
ferric ions in ferric oxides into ferrous ions and then transforming the hydrous 
iron oxides into magnetite nanoparticles with defined uniform structures.  
From the currently available information, it seems that different 
magnetotactic bacterial strains adopt different strategies to transport iron into 
magnetosome vesicles in different redox forms. In the Magnetospirillum 
magneticum Strain AMB-1, it has been reported that iron is transported into 
magnetosome vesicles in the form of Fe (II). The protein Mag A, which is 
believed to be a homolog of the cation-efflux protein Kef C in Escherichia coli, 
is involved in iron transport in the Magnetospirillum magneticum Strain AMB-1 
(Nakamura, Burgess et al. 1995). Studies on iron transport in the 
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Magnetospirillum magnetotacticum strain MS-1 demonstrated that Fe (II) is 
transported into magnetosome vesicles with the aid of siderophores (Paoletti 
and Blakemore 1986). In the Magnetospirillum gryphiswaldense Strain MSR-1, 
evidence showed that iron is mainly taken up into magnetosome vesicles in 
the form of Fe (III) without the involvement of siderophores (Schuler and 
Baeuerlein 1998; Bazylinski and Frankel 2004) and converted into Fe3O4 
immediately without any intermediate stages (Schüler and Baeuerlein 1996; 
Schuler and Baeuerlein 1998). 
Magnetotaxis 
The term ‘magnetotaxis’ was first used by R.P. Blakemore to describe the 
responses of magnetotactic bacteria to external magnetic fields (Blakemore 
1982). As R.P. Blakemore claimed, “The term of magnetotactic bacteria is only 
a descriptor and has no taxonomic meaning. Magnetotaxis denotes cell 
mobility directed by a magnetic field” (Blakemore 1982). In fact, the response 
of magnetotactic bacteria to external magnetic fields can be more accurately 
described as ‘magneto-aerotaxis’ rather than ‘magnetotaxis’ (Frankel, 
Bazylinski et al. 1997). As the term magneto-aerotaxis implies, the magnetic 
response of magnetotactic bacteria to the external field aligns cells along the 
magnetic field line, while the sensitivity of cells to the oxygen concentration or 
redox gradients determines the direction of their migration (Frankel, Bazylinski 
et al. 1997; Komeili 2007). Now, the term magnetotaxis is used as an 
abbreviation of magneto-aerotaxis. 
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Since the report of the first magnetotactic bacterial strain (Blakemore 
1975), different strains of magnetotactic bacteria have been found globally. 
Different strains of magnetotactic bacteria exhibit interesting migration patterns 
under local geomagnetic fields: Magnetotactic bacteria discovered in the 
Northern Hemisphere have a preferred migration pattern parallel to the 
magnetic field, exhibit a northward migration in the geomagnetic field, and are 
termed north-seeking (NS) magnetotactic bacteria (Blakemore 1975). 
Magnetotactic bacteria discovered in the Southern Hemisphere have a 
preferred migration pattern anti-parallel to the magnetic field, exhibit a 
southward migration in the geomagnetic field, and are termed south-seeking 
(NS) magnetotactic bacteria (Blakemore, Frankel et al. 1980). Amongst the 
magnetotactic bacteria discovered in the environments near the geomagnetic 
equator, both south-seeking and north-seeking magnetotactic bacteria are 
equally distributed (Frankel, Blakemore et al. 1981). 
To explain these observations of north and south seeking bacteria, R.P. 
Blakemore proposed the original model regarding the possible function of 
magnetotaxis: The geomagnetic field line is tilted downward from the horizon 
in the Northern Hemisphere and upward in the Southern Hemisphere. 
Therefore, NS magnetotactic bacteria in the Northern Hemisphere and SS 
magnetotactic bacteria in the Southern Hemisphere actually both move 
downwards along the tilted geomagnetic field lines. Magnetotaxis provide the 
guidance for the migration of cells to a low oxygen concentration sediments, 
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where they are supposed to stop swimming and adhere to the sediment 
particles (Blakemore 1975; Blakemore 1982; Bazylinski and Frankel 2004). 
This hypothesis is consistent with the distribution of NS and SS magnetotactic 
bacteria on the geosphere (Blakemore 1975; Blakemore, Frankel et al. 1980; 
Frankel, Blakemore et al. 1981; Bazylinski and Frankel 2004). 
However, this original model regarding magnetotaxis in magnetotactic 
bacteria has some drawbacks: First, this hypothesis did not give convincing 
explanation for the benefit magnetotaxis can bring to the magnetotactic 
bacteria in anoxic aqueous environments. Second, this hypothesis cannot 
explain how magnetotactic coccoid bacteria form microaerophilc bands in 
semi-solid, oxygen-gradient media (Bazylinski and Frankel 2004). The facts 
that large populations of magnetotactic bacteria are discovered at the 
‘oxic-anoxic’ interface of aqueous environment and some magnetotactic 
coccoid bacterial strains are obligate microaerophiles (Blakemore, Frankel et 
al. 1980; Frankel, Bazylinski et al. 1997) led to the birth of the term 
‘magneto-aerotaxis’, which is thought to be a more accurate description of the 
unique trait of magnetotactic bacteria (Frankel, Bazylinski et al. 1997). 
In their report describing the magneto-aerotactic trait of magnetotactic 
bacteria, Frankel et al. investigated the migration patterns in capillary tubes of 
various strains of NS magnetotactic bacteria in oxygen-concentration 
gradients. The results clearly demonstrated the joint effects of magnetotaxis 
and aerotaxis in the magnetotactic bacterial strains investigated (Frankel, 
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Bazylinski et al. 1997). In an aqueous environment, these magnetotactic 
bacteria usually migrate towards one direction (north). However, these NS 
magnetotactic bacteria reversed the direction of their movements towards the 
higher oxygen concentration when they were put in an oxygen concentration 
lower than the optimal oxygen concentration required for their growth (Frankel, 
Bazylinski et al. 1997; Bazylinski and Frankel 2004). 
The current explanation of the function and mechanism of magnetotaxis is 
that magnetotactic bacteria use magnetosomes aligned in chains inside 
themselves to act as compass needles to direct their migration downwards 
along the tilted geomagnetic line to find the optimal microaerobic or anaerobic 
environment for their growth. The magnetotactic trait of magnetotactic bacteria 
can simplify their search for the preferred microaerobic or anaerobic condition 
to a two dimensional rather than a random three dimensional search 
(Blakemore 1975; Frankel, Bazylinski et al. 1997; Bazylinski and Frankel 2004; 
Komeili 2007). Recent results also demonstrated that magnetotactic bacteria 
move more quickly and efficiently towards the preferred microaerobic or 
anaerobic in an applied magnetic field (Smith, Sheehan et al. 2006).  
Recently, a novel species of south-seeking magnetotactic bacteria has 
been found in the Northern Hemisphere (Simmons, Bazylinski et al. 2006). 
Magnetotactic bacteria with opposing polarities were found coexisting in the 
same redox environment found in the Northern Hemisphere and the 
percentage of magnetotactic bacteria with the south-seeking migration pattern 
10 
increases with redox potential (Simmons, Bazylinski et al. 2006). These 
south-seeking magnetotactic bacteria found in the Northern Hemisphere move 
upwards along the geomagnetic field lines and towards a higher oxygen level 
which is away from their preferred microaerobic oxygen environments and is 
opposite to all previously reported magnetotactic bacterial strains (Simmons, 
Bazylinski et al. 2006). 
The size of magnetite crystals synthesized by magnetotactic bacteria is 
within the single-magnetic-domain (SD) size range (Dunlop 1973; Butler and 
Banerjee 1975). Magnetite particles within the SD size range are permanently 
magnetic and the magnetic moments remain stable in ambient environments 
(Bazylinski and Frankel 2004; Komeili 2007). Magnetite particles smaller than 
the SD size are superparamagenetic and their magnetic moments are not 
permanent in ambient environments (Bazylinski and Frankel 2004).  
Under transmission electron microscopy (TEM), the magnetite particles 
synthesized by magnetotactic bacteria can be seen as chain(s) within the cell  
(Blakemore 1975; Frankel, Blakemore et al. 1979; Bazylinski and Frankel 
2004). In the first paper investigating the physical properties of bacterial 
magnetite particles, the authors assumed that the total magnetic moments of 
the whole cell were the sum of the magnetic moments of individual SD 
magnetic particles and had a calculated magnetic moments as 1.3X10-12 
electromagnetic units, which provided enough magnetic moment for cells to 
align themselves along geomagnetic field lines as low as 0.5 gauss (Frankel, 
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Blakemore et al. 1979). Subsequent light-scattering measurements of 
magnetic-moment of the Magnetospirillum magnetotacticum strain MS-1 
(Rosenblatt, Dearaujo et al. 1982), remanence measurements on individual 
Aquaspirillum magnetotacticum ATCC 31632 (Penninga, de Waard et al. 1995) 
and magnetic force microscopy of the submicron magnetic assembly of the 
marine magnetotactic vibrio strain MV-1 (Proksch, Schaffer et al. 1995)  
confirmed this calculation. It has been concluded that the magnetite particles 
synthesized by magnetotactic bacteria, aligned into chain(s) that are fixed 
within cells, act as “tiny compass needles” to direct the migration of 
magnetotactic bacteria (Bazylinski and Frankel 2004). It is the chain-aligned 
magnetite particles fixed inside the cells that confer the magnetotactic trait on 
magnetotactic bacteria. 
Magnetosome 
All magnetotactic bacteria have very unique intracellular structures in the 
magnetosomes. Magnetosomes are vesicles each with the magnetite 
nanocrystal (usually 35~120 nm in diameter) inside and a lipid bilayer 
membrane with similar composition as the cytoplasmic membrane (Balkwill, 
Maratea et al. 1980; Bazylinski and Frankel 2004; Komeili 2007). These 
vesicles are organized into chains by cytoskeletal filaments and fixed inside 
the cells  (Komeili 2007). The magnetite nanoparticles are the physical basis 
of the magnetotactic trait and the chain alignment of the magnetosome 
vesicles are the biological basis for this trait (Frankel and Bazylinski 2006; 
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Komeili 2007). 
The term ‘magnetosome’ was first used by Balkwill et al. to describe “the 
electron-dense particles and their associated bounding layers in magnetotactic 
bacteria” (Balkwill, Maratea et al. 1980). In that report, the authors claimed that 
individual magnetosomes are linked together to form a chain. The 
magnetosome chain is fixed to the inner cytoplasmic membrane of the cell 
(Balkwill, Maratea et al. 1980).  
Characterization of the magnetosome membrane was first reported in 
1988 by Gorby et al. (Gorby, Beveridge et al. 1988). The magnetosome 
membrane in Magnetospirillum maglonetotacticum strain MS-1 is a lipid bilayer 
with a 3-4 nm thickness. The components of magnetosome membranes are 
mainly phospholipids, fatty acids and some proteins, which are similar to those 
found in the cytoplasmic membranes of magnetotactic bacteria (Gorby, 
Beveridge et al. 1988).  
Although the observation that the magnetosome membrane has a similar 
composition to the cytoplasmic membrane indicates that the magnetosome 
membrane may originate from the cytoplasmic membrane, there was no clear 
and conclusive experimental report regarding the molecular mechanism of 
magnetosome formation until 2006 (Komeili, Li et al. 2006). 
One critical question regarding magnetosomes in magnetotactic bacteria 
since their discovery about 30 years ago is how magnetosome vesicles are 
formed and aligned into chains. It has been long speculated that the formation 
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and chain alignment of magnetosome vesicles are under genetic control 
(Bazylinski, Frankel et al. 1995; Frankel and Bazylinski 2006). However, 
detailed investigation of the molecular mechanisms of magnetosome formation 
was impossible until recently after the genomes of several magnetotactic 
bacteria, Magnetospirillum magneticum strain AMB-1 (Matsunaga, Okamura et 
al. 2005), Magnetospirillum magnetotacticum strain MS-1 (Joint Genome 
Institute, http://genome.jgi-psf.org/draft_microbes/magma/magma.home.html), 
and Magnetospirillum magneticum strain MC-1 (Joint Genome Institute, 
http://genome.jgi-psf.org/draft_microbes/magm1/magm1.home.html), were 
sequenced and annotated (Frankel and Bazylinski 2006). 
In 2004, Komeili et al. used the Magnetospirillum magneticum strain 
AMB-1 as the model system and clearly demonstrated that magnetosome 
vesicles are present before magnetite formation, and that the protein MamA is 
required for their activation (Komeili, Vali et al. 2004). By using 
cryo-ultramicrotomy, the authors observed intact chains of empty 
magnetosome vesicles in magnetotactic bacteria cultured under iron-limited 
conditions. This result demonstrated that magnetosome vesicles are formed 
and aligned into chains before magnetite synthesis. Deletion of the mamA 
gene, a gene encoding magnetosome protein MamA, resulted in shorter 
magnetosome chains (1-5 vesicles per cell) being synthesized inside the cells. 
The authors proposed two possible functions of the protein MamA in 
magnetosome formation: One function of MamA is that it may be involved in 
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magnetosome assembly. Another possibility is that MamA may be used by 
magnetotactic bacteria to control the number of magnetosome vesicles they 
synthesize and therefore the length of magnetosome chains when there is not 
enough iron available (Komeili, Vali et al. 2004). 
In a recent review, Komeili proposed the molecular mechanism of 
magnetosome formation in the Magnetospirillum magneticum Strain AMB-1  
(Komeili 2007). This model involves three steps: First, membrane invagination 
occurs at the inner part of the cytoplasmic membrane of the magnetotactic 
bacteria. Second, individual invaginations are assembled into a chain by 
MamK and MamJ. Third, iron is transported into the magnetosome vesicles 
and the synthesis of magnetite nanocrystals with defined structures is 
stimulated by Mms6 (Bazylinski and Frankel 2004; Komeili 2007). In this model, 
evidence regarding membrane invagination and magnetosome vesicle 
assembly is convincing, but the mechanism of Mms6 stimulated magnetite 
nanocrystal formation inside magnetosome vesicles remains unclear. 
In 2006, two research groups reported the functions of protein MamJ and 
MamK in magnetosome formation in different Magnetospirillum strains. 
Komeili et al. investigated the functions of the magnetosome protein MamK in 
magnetosome formation in the Magnetospirillum magneticum strain AMB-1  
(Komeili, Li et al. 2006). The authors used electroncryotomography (ECT) to 
study magnetosome formation. When cells were grown in iron-limited 
conditions, empty magnetosome chains were observed (Komeili, Li et al. 
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2006). The ECT images clearly showed that about 34 % of the magnetosome 
vesicles were invaginations of the inner membrane and that the remaining   
66 % were located close enough to the membrane to be the results of 
invaginations (Komeili, Li et al. 2006). These results demonstrated that 
magnetosome vesicles originate from the invagination of the inner cytoplasmic 
membranes of the cells. Deletion of the mamK gene, a gene encoding the 
magnetosome protein MamK, disrupted the magnetosome chains and the 
magnetosome vesicles were dispersed in the cells (Komeili, Li et al. 2006). 
Complementation of the ΔmamK mutant with mamK–GFP restored the 
magnetosome chains (Komeili, Li et al. 2006).The authors concluded that the 
protein MamK, a homolog of the bacterial actin-like protein MreB, forms 
cytoskeletal filaments  that align individual magnetosome vesicles into chains 
that are fixed in the cell (Komeili, Li et al. 2006).  
Scheffel et al. investigated the role of the other acidic magnetosome 
protein MamJ in the formation of magnetosomes in Magnetospirillum 
gryphiswaldense. In the deletion mutant of mamJ, the magnetosome vesicles 
clustered together and no longer formed chains. By using mamJ-eGFP and 
Electroncryotomography (ECT), the authors demonstrated that the MamJ 
protein was localized adjacent to a filament that extended through the length of 
cell. When cells were cultured under iron-insufficient conditions, empty 
magnetosome vesicles linked to the linear filament were observed in wild type 
cells. However, in ΔmamJ mutants, empty vesicles were dissociated from the 
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filaments when cultured with insufficient iron (Scheffel, Gruska et al. 2006). 
The authors proposed a model for magnetosome chain formation: First MamJ 
links empty magnetosome vesicles to the cytoskeletal filaments inside cells. 
Then magnetite particle synthesis initiates inside the vesicles. As the 
magnetite particles continue to grow, the magnetic moments between the 
particles start to take effect and bring them together, forming stable 
magnetosome chains (Scheffel, Gruska et al. 2006). 
Biomineralization Protein--Mms6 
The Mms6 protein was first reported by Arakaki et al. as a magnetosome 
membrane-associated protein which is tightly bound to magnetite 
nanoparticles isolated from the Magnetospirillum magneticum strain AMB-1 
(Arakaki, Webb et al. 2003). In their report, Arakaki et al. identified several 
small proteins, Mms5, Mms6, Mms7, Mms13, which were tightly bound to the 
bacterial synthesized magnetite nanoparticles. These proteins cannot be 
extracted from magnetosome membranes by a solution containing 7 M urea, 2 
M thiourea and 4 % CHAPS and can only be solubilized by boiling in 1 % SDS 
(Arakaki, Webb et al. 2003).  
These small proteins are encoded by the mamCD and mms6 gene 
clusters, which are adjacent to each other in the Magnetospirillum magneticum 
strain AMB-1 genome (Grunberg, Wawer et al. 2001; Komeili 2007). Mms5, 
Mms6 and Mms7 share some common features: They all have a hydrophobic 
N-terminal domain, which is proposed to be the membrane domain of these 
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proteins, and a hydrophilic C-terminal domain, which may be involved in 
magnetite nanoparticle formation. The most intriguing finding in this report is 
that magnetite nanoparticles with similar morphology to bacterial magnetites 
can be chemically synthesized in vitro in the presence of purified recombinant 
Mms6 that was expressed in E.coli (Arakaki, Webb et al. 2003). But the critical 
magnetization measurements and structural characterizations of these 
magnetite particles synthesized in the present of recombinant Mms6 protein 
were lacking in this report. 
In 2007, Prozorov et al. reported magnetization measurements and 
structural characterization of magnetite nanoparticles synthesized in the 
presence of recombinant Mms6 protein (T. Prozorov 2007). The authors used 
BSA, ferritin and Lcn2 as controls to compare magnetite particles synthesized 
in the present of proteins with different iron binding properties. The 
magnetization measurements and transmission electron microscopy results 
clearly demonstrated that magnetite particles with defined structures can only 
be synthesized when Mms6 is present (T. Prozorov 2007).  
Recently, Prozorov et al. reported the synthesis of cobalt ferrite 
nanocrystals in the presence of His-Mms6 and its C-terminus (T. Prozorov 
Accepted, In press). The authors covalently attached His-Mms6 and the 
C-terminus of Mms6 to self-assembling polymers and used the resulting 
polymers as templates to synthesize cobalt ferrite nanocrystals. The resulting 
cobalt ferrite nanocrystals exhibited 50-80 nm thin hexagon-like structures that 
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are difficult to produce using conventional techniques. The authors claimed 
that when the self-assembling polymers were covalently attached with 
His-Mms6 or its C-terminus, they may act in a manner similar to the bacterial 
magnetosome membranes and allow a surface-controlled crystal growth (T. 
Prozorov Accepted, In press). 
The hydrophilic C-terminal region of Mms6 contain a series of amino acid 
residues with either hydroxyl or carboxyl groups. It has been speculated that 
Mms6 may act as a template for magnetic nanoparticle synthesis and can 
control the morphology of the magnetite (Arakaki, Webb et al. 2003). But, there 
is no further research or evidence to support this hypothesis. The exact role of 
Mms6 in magnetite crystal formation in the Magnetospirillum magneticum 
Strain AMB-1 remains unclear. 
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MATERIALS AND METHODS 
Expression and purification of His-Mms6 
To clone the mms6 gene, genomic DNA containing the mms6 gene was 
extracted from Magnetospirillum magneticum strain AMB-1 (Obtained from Dr. 
Dennis Bazylinski) using QIAamp DNA Mini Kit (Qiagen). Primer sets 
5’-GGGGGACATATGGTCGGTGGAACCATCTGGACCGGTAAG-3’ and 
5’-GGGGGATCCAAATCAGGCCAGCGCGTCGCGCAGTTCGAC-3’ were 
used to amplify the mms6 gene from AMB-1 genomic DNA. The conditions for 
PCR amplification was: 60 °C annealing temperature, 5.0 mM MgCl2. 
The polymerase chain reaction (PCR) amplicon was then cloned into the 
plasmid pTrcHis TOPO such that the Mms6 sequence is in frame with an 
N-terminal polyhistidine tag (Invitrogen, Carlsbad, CA). This cloned expression 
vector was used to prepare recombinant His-Mms6. Cells of Escherichia coli 
transformed by Mms6 expression vectors were used to produce His-Mms6. 
The protein was expressed in E.coli stimulated by isopropyl 
β-D-1-thiogalactopyranoside (IPTG).  
Some of the expressed His-Mms6 was found in the soluble fraction of the 
bacterial lysates. However, a large fraction of the expressed His-Mms6 was 
insoluble and present in inclusion bodies. The expressed soluble His-Mms6 
protein was captured from the bacterial cell lysate with Talon metal affinity 
column (BD Biosciences, Clontech, Mountain View, CA). The resin was first 
washed with 20 mM Tris-HCl, 100 mM KCl, 30 mM imidazole, 0.2 mM PMSF, 
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pH 7.5. The His-Mms6 was then eluted from the column by 20 mM Tris-HCl, 
100 mM KCl, 300 mM imidazole, 0.2 mM PMSF, pH 7.5. The expression and 
purification of His-Mms6 under denaturing condition were done by Pierre Palo. 
The inclusion bodies were dissolved in 7 M urea and captured with Talon 
metal affinity column (Clontech, Mountain View, CA). The resin was then 
washed with 20 mM Tris-HCl, 500 mM KCl, 7 M urea, 0.2 mM PMSF, 30 mM 
imidazole, pH 7.5. The denatured His-Mms6 was then eluted from the column 
using 20 mM Tris-HCl, 500 mM KCl, 300 mM imidazole, 0.2 mM PMSF, 7 M 
urea, pH 7.5. The refolding of His-Mms6 was achieved by a series of dialyses 
against decreasing concentrations of urea in 20 mM Tris-HCl, 0.2 mM PMSF, 
500 mM KCl, pH7.5. The purified proteins were examined by 15 % SDS-PAGE 
stained with Coomassie Blue and by western blot on which His-Mms6 was 
detected with anti-His-tag antibodies (Amersham Biosciences, Piscataway, 
NJ) 
Mass spectra and N-terminal sequencing were used to examine whether 
the recombinant His-Mms6 was correctly expressed and purified. For mass 
spectra, the purified His-Mms6 was exchanged into 10 mM Na2HPO4, pH 7.0 
by dialysis. The mass spectrum of His-Mms6 was obtained using a 
ThermoBioAnalysis Dynamo MALDI mass analyzer in Protein Facility at Iowa 
State University.  
For N-terminal amino acid sequence analysis, His-Mms6 was first resolved 
on 15 % SDS-PAGE gel and electroblotted onto an Immobilon-PSQ 
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membrane (Millipore Corp., Billerica, MA). The membrane was then stained 
with Coomassie Blue and the protein band was excised. The N-terminal amino 
acid sequence of His-Mms6 was determined by Edman degradation (Smith, 
Edman et al. 1962) using an Applied Biosystems 492 Procise Protein 
Sequencer coupled with a model 140C Analyser by the Protein Facility at Iowa 
State University.  
 
Enterokinase cleavage of His-Mms6 
His-Mms6 purified by Talon metal affinity column was first exchanged into 
20 mM Tris-HCl, pH 7.5 by dialysis (MWCO3500, Spectrum). The reaction 
mixture containing 24 μM His-Mms6, 0.012U/μl recombinant enterokinase 
(Novagen, San Diego, CA), 28 mM Tris-HCl, 50 mM NaCl, 2 mM CaCl2, pH 7.5 
was incubated at 25 °C for 24 hours. It has been reported that recombinant 
enterokinase has an optimal enzyme activity when the Ca2+ concentration in 
the reaction system was 20 μM (Gasparian, Ostapchenko et al. 2006). So, the 
effect of Ca2+ concentration on enterokinase enzyme cleavage was also 
investigated by using the same experiment conditions as above except the 
Ca2+ concentration was 20 μM. The reaction was stopped at 2, 6, and 24 hours 
by heating the sample at 100 °C for 5 minutes. The extent of cleavage was 
analyzed by 15 % SDS-PAGE stained with Coomassie Blue. The His-Mms6 
sample treated with rEK under the above conditions for 24 hours was 
exchanged into 10 mM Na2HPO4, pH 7.0 by dialysis (MWCO3500, Spectrum, 
22 
Gardena, CA) and analyzed using a ThermoBioAnalysis Dynamo MALDI mass 
analyzer in Protein Facility at Iowa State University.  
 
Iron binding measurements 
The iron binding activity of His-mms6 was quantitatively compared with a 
series of control proteins by filter assay. For the filter assay, 0.67 μM of 
His-Mms6, ferritin (CalBiochem, San Diego, CA), His-Lcn2, Lcn2, and BSA 
were incubated in separate test tubes for one hour each with 10 μM Fe55 
(PerkinElmer, Waltham, MA), 22 mM Tris-HCl,150 mM NaCl, 10 mM KCl and  
2 % glycerol, pH 7.0 (at 25 °C) under argon. The samples were then filtered 
through 0.45 μM nitrocellulose membranes (Millipore, Billerica, CA) prewashed 
with 20 mM Tris-HCl, 150 mM NaCl, pH 7.0 (at 25 °C). The membranes were 
washed with two consecutive 5 ml washes with 20 mM Tris-HCl, 150 mM NaCl, 
pH 7.0 (at 25 °C) then removed and counted using scintillation solution 
(Scintiverse BD LSC Cocktail, Fisher Scientific, Pittsburg, PA) and liquid 
scintillation analyzer (Packard model 1600 TR). Buffers used for this analysis 
of binding capability were degassed and sparged with argon for 1 hour before 
use.  
The iron binding of His-Mms6 was measured by Isothermal titration 
calorimetry (ITC). ITC measurements were carried out at 25 °C on a VP-ITC 
instrument (MicroCal, Northampton, MA). Ferric chloride was used as the 
titrant. The titrant and sample solutions were degassed for 5 minutes before 
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titration. The first 1μl of 100 μM FeCl3 followed by 30 injections of 100 μM 
FeCl3 with 10 μl of each were titrated into 1.4 ml of 10 μM His-Mms6, 20 mM 
Tris-HCl, 100 mM KCl, pH 7.5 with 5 min intervals between each injection to 
allow complete equilibration. A titration of 100 μM FeCl3 into 10 μM transferrin 
(Sigma-Aldrich Corp., St. Louis, MO) under same experimental conditions was 
used for comparison. A titration of 100 μM FeCl3 into 20 mM Tris-HCl, 100 mM 
KCl, pH 7.5 in the sample cell was used as background and subtracted from 
each experimental titration to account for the heat of dilution. The data were 
collected automatically and analyzed by Origin software package supplied by 
MicroCal.  
The iron binding activity of His-Mms6 was also investigated by UV-visible 
spectra. The UV-visible spectra of transferrin (Sigma-Aldrich Corp., St. Louis, 
MO) and BSA (Sigma-Aldrich Corp., St. Louis, MO) in different concentrations 
of FeCl3 were used for comparison. All protein samples were rendered free of 
iron by the following series of dialyses: twice with 0.1 M citrate, pH 4.5, twice 
with 0.1 M sodium perchlorate, pH 4.5, twice with distilled water, and twice with 
20 mM Tris-HCl, 0.15M NaCl, pH 7.0 (Aisen, Leibman et al. 1966). Protein 
samples were incubated in 18 mM Tris-HCl, 140 mM NaCl, pH 7.0 for 30 
minutes with different concentrations of FeCl3 as specified in the legends to the 
figures. The UV-visible spectra were recorded by a ND-100 Spectrophotometer 
(NanoDrop Technologies Inc, Wilmington, DE) which scanned from 220 nm to 
750 nm. 
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Expression and purification of recombinant GST-Mms6 
Genomic DNA containing the mms6 gene was obtained from 
Magnetospirillum magneticum strain AMB-1 and cloned into plasmid 
ptrchis-TOPO (Invitrogen, Carlsbad, CA) to express Mms6 with a N-terminal 
polyhistidine tag as previously described (T. Prozorov 2007). Primer set 
5’-AACGGATCCGGTGGAACCATCTCCACC-3’ and 5’-ATTGAATTCTCAGGC 
CAGCGCCGTCGCG3’ were used to amplify the mms6 gene from the above 
plasmid by the polymerase chain reaction (PCR) and the amplicon was 
subcloned into vetor pGEX4T-1 (GE healthcare, Piscataway, NJ) such that the 
Mms6 sequence is in frame with an N-terminal GST tag. This recombinant 
plasmid was named as pcGST-mms6 and transformed into E.coli DH5α. The 
expression and purification of GST-Mms6 were done by Pierre Palo. 
The GST-Mms6 was expressed in Escherichia coli stimulated by isopropyl 
β-D-1-Thiogalactopyranoside (IPTG). For its purification, GST-Mms6 was 
captured from the bacterial cell lysate using Glutathione-Superflow resin 
(Clontech, Mountain View, CA). The resin was washed 3 times with 140 mM 
NaCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.5, 4 °C. Then GST-Mms6 was 
eluted with 10 mM glutathione, 50 mM Tris-HCl-Cl, pH 8.0, 4 °C. The protein 
concentration was determined by the Bradford protein assay (Bradford 1976). 
The purified protein was evaluated by gel electrophoresis and western blot 
using anti-GST antibodies (Invitrogen, Carlsbad, CA). 
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C-terminal domains of Mms6 and its mutant  
The C-terminal domain of Mms6 (C25Mms6: YAYMKSRDIESAQSDEEVE 
LRDALA,) and its mutant (C25Mms6K39A;R41A;R55A: YAYMASADIESAQS 
DEEVELADALA) were purchased from Genscript (Genscript Corporation, 
Piscatway, NJ, USA; Web: www.genscript.com) 
 
Analytical ultracentrifugation of His-Mms6 
Five hundred microliter of 0.46 mg/ml His-Mms6 in 137 mM NaCl, 2.7 mM 
KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2 was loaded into cells, placed 
in an AN60 rotor in a Beckman ProteomeLab XL-A analytical ultracentrifuge 
(Beckman, Fullerton, CA). The time-dependent sedimentation of His-Mms6 
was monitored at 280 nm, 30000 rpm, 4 °C for 2 hours. The profile of the 
sedimentation coefficients of His-Mms6 was generated by the method of van 
Holde and Weichet (K. E. Van Holde 1978; Demeler and van Holde 2004) 
using Ultrascan 8.0 for the Windows system (Demeler). 
 
Gel filtration chromatography 
Gel filtration chromatography was used to estimate the apparent molecular 
mass of His-Mms6, GST-Mms6, the C-terminal domain of Mms6 and its 
mutant. The elution profiles were generated by AKTA FPLC system (GE 
healthcare, Piscataway, NJ) and a prepacked Superdex G75 10/300GL 
column (GE healthcare, Piscataway, NJ) using a flow rate of 0.4 ml/min at 4 °C. 
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For His-Mms6, the elution profile was generated by AKTA FPLC system (GE 
healthcare, Piscataway, NJ) and a prepacked Superose 12 10/300GL column 
(GE Healthcare, separation range: 1 kD-300 kD) using a flow rate of 0.5 ml/min 
at 4°C.  
Blue Dextran (Sigma-Aldrich Corp., St. Louis, MO) was used to determine 
the void column volume (Vo), the elution volumes (Ve) of bovine serum album 
(MM 66 kD), ovalbumin (MM 44.3 kD), carbonic anhydrase (MM 29 kD), 
myoglobin (MM 17.6 kD), aprotinin (MM 6.5 kD) and B12 (MM 1355 Daltons) 
(all from Sigma-Aldrich Corp., St. Louis, MO) were used to generate the 
standard curves for apparent molecular mass estimations. All samples were 
centrifuged at 14000 g, 4 °C for 1 hour before loading on the column. For a 
typical gel filtration chromatography experiment, the column was equilibrated 
with 50 ml buffer as specified in the legends to the figures, then 100 μl~500 μl 
of sample was loaded on the column followed by 37.5 ml buffer to elute. The 
standard curve was generated by plotting Ve/Vo versus log (MM) and used to 
estimate the apparent MM of the proteins in question. 
 
Dynamic light scattering (DLS) 
The size of His-Mms6 was measured by a DLS instrument (Zetasizer 
Nanoparticle analyzer, Model: ZEN3690, Malvern Instrument Ltd., 
Southborough, MA). One hundred microliter of 0.5 mg/ml His-Mms6 in 137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2 was loaded into 
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the cuvette. The measurements were performed at 25 °C. Each measurement 
consisted of 11 acquisitions of 10 seconds each that was repeated 3 times. 
Data were processed by using Dispersion Technology Software 5.00 (Malvern 
Instrument Ltd., Southborough, MA), buffer used for DLS measurements was 
filtered through a 0.45 μm nitrocellulose membrane and the protein samples 
were centrifuged for 1 hour (14000 g, 4 °C) prior to use. 
  
Magnetite nanoparticle synthesis 
Synthesis of the magnetite nanoparticles in the presence of different 
proteins and peptides was carried out via co-precipitation of FeCl2 and FeCl3 in  
the F-127 Pluronic aqueous solution following the methods described 
previously (T. Prozorov 2007). For a typical experiment, a 1.1 ml solution 
containing 8.18 μg/ml His-Mms6, Ferritin, BSA, His-Lcn2, GST-mms6, GST or 
C25Mms6, 1.82 mM Tris-HCl, 9.09 mM KCl, 18.2 % Pluronic (BASF, Florham 
Park, NJ), pH 7.5 was degassed and sparged with argon at 4 °C for 3 minutes. 
The above solution was then mixed with 50 μl of 0.5 M FeCl3 and 50 μl of  
0.25 M FeCl2 and the pH adjusted with the addition of 800 μl of 0.1 M NaOH to 
the black endpoint. The resulting solution was degassed and sparged with 
argon at 25 °C for 3 minutes.  
Nanoparticles were allowed to grow and precipitate at pH 7, 25°C in 
sealed glass test tubes. After 5 days, the nanoparticles were concentrated at 
the bottom of the test tube with a magnet. An aliquot of magnetically separated, 
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concentrated suspension was taken for scanning transmission electron 
microscope (STEM) measurements. All solutions were degassed and sparged 
with argon for 30 minutes before use. All reactions were performed in 5 ml 
sealed glass test tubes under constant argon flow. Nanoparticle syntheses 
were done by Tanya Prozorov. 
 
Scanning transmission electron microscope (STEM) 
Diluted magnetite nanoparticle suspensions were placed on holey 
carbon-coated copper grids and dried at 25 °C. Particle sizes and 
morphologies of the magnetite samples were examined by using a Tecnai G2 
F20 STEM (FEI Company, Hillsboro, OR) operated at 200 kV accelerating 
voltage. STEM measurements were performed by Tanya Prozorov.  
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RESULTS AND DISCUSSION 
Expression and purification of His-Mms6 
The mms6 gene was extracted from Magnetospirillum magneticum AMB-1 
and cloned into E.coli. The protein was expressed in Escherichia coli 
stimulated by isopropyl β-D-1-thiogalactopyranoside (IPTG). The purified 
proteins were examined by 15 % SDS-PAGE stained with Coomassie Blue 
and by western blot on which His-Mms6 was detected with anti-His-tag 
antibodies  (Fig. 1A, B, Data from Pierre Palo). The results indicate that the 
purified protein has the poly-His tag and its apparent molecular mass on 
SDS-PAGE gel is about 16 kD. 
Mass spectra and N-terminal sequencing were used to examine whether 
the recombinant His-Mms6 was correctly expressed and purified. The mass 
spectrum results show that His-Mms6 has a measured molecular mass of 
10258.08 Daltons, which matches the molecular mass of 10297.51 Daltons 
calculated from the amino acid sequence of His-Mms6 (Fig. 1C). The 
N-terminal amino acid sequence of His-Mms6 result shows that the first seven 
amino acids at the N-terminus of His-Mms6 are GGSHHHH (Fig. 1D).  
Both the mass spectrum and N-terminal amino acid sequence results 
confirmed that His-Mms6 has been correctly expressed and purified. 
 
Recombinant enterokinase cleavage of His-Mms6 
His-Mms6 was expressed with a recombinant enterokinase cleavage site 
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between the poly-histidine tag and the mature Mms6 protein. Fig. 2 shows the 
result of recombinant enterokinase cleavage on His-Mms6. The SDS-PAGE 
gel showed a band shift after His-Mms6 was treated with a 1 U: 20 μg enzyme 
to His-mms6 ratio in 2 mM CaCl2 buffer, which indicated there was a cleavage 
during rEK treatment of His-Mms6 (Fig. 2A). At 20 μM Ca2+, no band shift was 
observed. The mass spectrum identified 3 fragments after His-Mms6 was 
treated by rEK for 24 hours (Fig. 2B). None of the measured molecular masses 
matches the expected molecular mass of His-Mms6 after His-tag removal. The 
results indicated that rEK may non-specifically cleave the peptide bond 
between R and D at C-terminal of His-Mms6 as well as the engineered 
enterokinase cleavage site (Fig. 2C). The recombinant enterokinase cleavage 
results also indicate that His-Mms6 may form a complex which makes the 
recombinant enterokinase cleavage site inaccessible to the enzyme.  
 
Magnetite nanoparticles synthesized in the presence of His-mms6 
To confirm that His-Mms6 can stimulate the formation of magnetite 
nanoparticles with defined uniform structures, we synthesized magnetite 
particles in the presence of His-Mms6 as well as other control proteins and 
examined the sizes and morphologies of these particles by TEM (Particle 
synthesis and analyses done by Tanya Prozorov). Fig. 3 (Data from Tanya 
Prozorov,(T. Prozorov 2007)) shows the TEM images of magnetite particles 
synthesized in the presence of His-Mms6 or different control proteins.  
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Magnetite particles synthesized in protein free solutions (Fig. 3A) lacked 
size and shape uniformity. The magnetite nanoparticles synthesized in the 
presence of His-Mms6 exhibited a uniform and defined morphology, with a 
mean crystallite size of about 30 nm (Fig. 2B). Magnetite particles synthesized 
in the presence of ferritin (Fig. 3C) contained a large number of ill-defined 
particles of significantly smaller sizes than those synthesized in the presence 
of His-Mms6. Similar results were found from magnetite particles synthesized 
in the presence of His-Lcn2 (Fig. 3D). The magnetite particles formed in the 
presence of BSA (Fig. 3E) lacked defined morphology. Based on the above 
results, we may conclude that the His-tags present in both His-Mms6 and 
His-Lcn2 are unlikely to contribute the formation of magnetite nanoparticles 
with defined uniform structure, and that His-Mms6 can stimulate the formation 
of magnetite nanoparticles with defined uniform structures.  
 
Iron binding activity of His-Mms6 
The iron binding ability of His-Mms6 was initially examined by a dot assay 
described in the paper reporting the discovery of Mms6 (Arakaki, Webb et al. 
2003). This assay was tested but abandoned after several trials showing 
inconsistent results. The iron binding activity of His-Mms6 was then 
investigated using a filter assay and Fe55 (Fig. 4). The filter assay results show 
that His-Mms6 binds slightly less iron than ferritin. However, it is possible that 
part of the iron binding ability of His-Mms6 may come from its His-tag as 
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shown by the comparison of the iron binding ability of His-Lcn2 and Lcn2. 
Once the His-tag is removed, Lcn2 has almost the same iron binding ability as 
BSA.  
The filter assay was also used to investigate the binding constant and 
stoichiometry of iron binding to His-Mms6. The concentration of His-Mms6 
used in this analysis was 90 nM throughout. The amount of 55Fe bound to the 
His-Mms6 was measured after incubation with 55Fe at concentrations ranging 
from 0 to 2μM. The binding buffer contained 0.01 % BSA that was used to 
block the nonspecific binding of 55Fe to the filters. The results in figure 5 shows 
the iron-binding curve of His-Mms6. By using a Scatchard plot, the Kd of the 
iron bound to His-Mms6 was estimated to be about 70 nM.  However, the 
stoichiometry showed that one mole of His-Mms6 can bound only 0.03 mole of 
55Fe. The result showed that, although there is evidence of binding, importantly 
it is not stoichiometric and so is unlikely to represent the actuality of Mms6 that 
promotes magnetites crystallization. It is possible that the His-Mms6 used in 
these experiments was already saturated by iron before the binding assay 
because it had not been subjected to a rigorous dialysis protocol to remove all 
iron. 
The iron-binding of His-Mms6 (depleted of iron as described in methods) 
was also measured by ITC (Fig. 6). The results in figure 6 show the ITC results 
of a titration of 100 μM FeCl3 into 10 μM His-Mms6. The measurement of 
iron-binding of transferrin under the same experimental conditions was used 
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for comparison. Both His-Mms6 and transferrin did not show any obvious 
binding to iron and the background was very large. Transferrin has a binding 
constant to Fe3+ as low as 10-18~-20 M (Aisen, Leibman et al. 1978). The titration 
of His-Mms6 also exhibited a similar pattern as transferrin. In the paper 
reporting the discovery of Mms6, Mms6 can only be extracted from bacterial 
magnetic particles by boiling in 1 % SDS (Yoza, Arakaki et al. 2003). So, we 
suspect that His-Mms6 might have very high affinity to Fe3+ comparable to 
transferrin. Further studies are needed to establish the correct conditions for 
examining iron binding of Mms6 by ITC.  
We also examined the UV-visible spectra of His-Mms6 in different 
concentrations of Fe3+ to investigate the iron binding property of His-Mms6 
(Fig. 7A). The UV-visible spectra of transferrin (Fig. 7B) and BSA (Fig. 7C) in 
different concentrations of FeCl3 were used for comparison. The UV-visible 
spectrum of transferrin show a characteristic peak for chelated iron at around 
470 nm.  The change in the 470 nm peak with increasing concentrations of 
iron showed that transferrin was saturated with iron at a 1:2 molar ratio to Fe3+, 
which is consistent with literature report (Aisen, Leibman et al. 1978). It has 
been reported that the increased absorption in the range from 300 to 400 nm 
of iron bound ferritin is due to the iron hydroxide stored within the protein cavity 
(Ilari, Ceci et al. 2002). In our experiments, the increased concentration of Fe3+ 
incubated with His-Mms6 or BSA resulted in increasing of absorption between 
300 nm to 600 nm, but no characteristic peak could be identified.  
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Quaternary structure of His-Mms6  
Previous studies showed that His-Mms6 can stimulate the formation of 
magnetite nanoparticles in vitro with similar size and shape to the bacterial 
magnetites (Arakaki, Webb et al. 2003; T. Prozorov 2007). To develop a model 
for the mechanism of Mms6 stimulated magnetite nanoparticle formation, we 
examined the quaternary structure of Mms6. We first used analytical 
ultracentrifugation to investigate the quaternary structure of His-Mms6 (Fig. 8). 
Fig. 8 shows the sedimentation coefficient distribution of His-Mms6 in 137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2. The 
sedimentation coefficient of His-Mms6 distributed from 1 S to 100 S with the 
majority between 20 S and 40 S. The theoretical molecular mass of His-Mms6 
is about 10 kD and the sedimentation coefficient of monomeric His-Mms6 
would be 1.16 S, assuming His-Mms6 is a globular protein. The result of the 
sedimentation coefficient distribution indicated that His-Mms6 may form large 
multimers with an estimated apparent molecular mass between 200 kD and 
400 kD. 
Gel filtration chromatography was also used to estimate the apparent 
molecular mass of His-Mms6. Fig. 9 shows the elution profile of His-Mms6 on 
the Superose 12 column. The elution profile of Blue Dextran was used to 
determine the void volume of the Superose 12 column. The peak of His-Mms6 
appeared in the void volume of Superose 12 column (the upper separation 
limit of Superose 12 column is 300 kD), which indicates that His-Mms6 has an 
35 
apparent molecular mass of at least 300 kD.  
Gel filtration chromatography was also used to examine the multimeric 
state of His-Mms6 under denaturing conditions. Fig. 10 shows the elution 
profile of His-Mms6 on the Superdex G75 column in 137 mM NaCl, 4.3 mM 
Na2HPO4, 2.7 mM KCl, 1.4 mM KH2PO4, 6 M GnCl (guanidine hydrochloride), 
pH 7.2. The elution profiles of BSA (MM 65 kD) and ferritin (monomeric MM 20 
kD) obtained under the same denaturing condition were used for comparison. 
The result indicates that even under denaturing conditions His-Mms6 forms 
multimers with an apparent molecular mass between 20 kD and 65 kD.  
Dynamic light scattering (DLS) was used to investigate the hydrodynamic 
radius of His-Mms6 (Fig. 11). Fig. 11 shows the size distribution of His-Mms6 
by volume measured by DLS. The size distribution of His-Mms6 appeared as 
two major peaks. About 59% (mass) of His-Mms6 has a mean hydrodynamic 
radius of 5.1 nm which corresponds to a globular mass with a molecular mass 
of about 200 kD, the remaining 41% (mass) of His-Mms6 showed a more 
broad size distribution with a mean hydrodynamic radius of 12.2 nm and an 
estimated molecular mass about 2000 kD assuming the shape of His-Mms6 is 
globular. The number of His-Mms6 molecules with a molecular mass about 
200 kD becomes dominant (>90 %) if we convert the mass based percentage 
distribution into molar based one.  
All the above results indicate that His-Mms6 molecules have strong 
interactions with each other and form large complexes. The molecular mass of 
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multimeric His-Mms6 varies and the majority of the protein distributes from  
200 kD to 400 kD. 
 
The presumed function of the C-terminal domain of Mms6 and its 
quaternary structure 
The full length Mms6 has a hydrophobic N-terminal domain, which is 
presumed to be the membrane domain of Mms6, and a hydrophilic C-terminal 
domain which may be involved in magnetite nanoparticle formation (Arakaki, 
Webb et al. 2003). We initially chose the 25 C-terminal amino acids of Mms6 
(C25Mms6: YAYMKSRDIESAQSDEEVELRDALA) to investigate the 
quaternary structure of the proposed functional domain of Mms6. First, we 
synthesized the magnetite nanoparticles in vitro in the presence of C25Mms6 
and examined the size and morphology of magnetite nanoparticles 
synthesized in the presence of C25Mms6. Fig. 12 shows the TEM images of 
C25Mms6 stimulated magnetite nanoparticles. The particles synthesized in 
the presence of C25Mms6 are mainly cubic with an average size between 30 
to 40 nm. The size and morphology of C25Mms6 stimulated magnetite 
nanoparticle are similar to the bacterial magnetites and the nanoparticles 
synthesized in the presence of His-Mms6 in vitro (Arakaki, Webb et al. 2003; T. 
Prozorov 2007).  
We used gel filtration chromatography to investigate the multimeric state of 
C25Mms6. Fig. 13 shows the elution profile of C25Mms6 on the Superdex G75 
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column at 0. 4 ml/min flow rate, 4 °C in 20mM Tris-HCl, 100 mM KCl, pH 7.5. 
By using the standard curve, the apparent molecular mass of C25Mms6 is 
estimated to be 11.3 kD that corresponds to a tetrameric C25Mms6 assuming 
the shape of C25Mms6 is globular. The calculated molecular mass of 
monomeric C25Mms6 is 2.9 kD.  
C25Mms6 contains a series of acidic and basic amino acid residues. It is 
reasonable to speculate that electrostatic interactions may be involved in the 
multimerization of C25Mms6. To test this hypothesis, the multimeric state of 
C25Mms6 in high salt buffer was investigated by resolving C25Mms6 on the 
Superdex G75 column at 0.4 ml/min flow rate, 4 °C in 20 mM Tris-HCl, 1.5 M 
KCl, pH7.5. Fig. 14 shows the elution profile of C25Mms6 in high salt buffer 
condition (1.5 M KCl). The elution volume of C25Mms6 was shifted from in 
front of aprotinin (100 mM KCl) to behind aprotinin (1.5 M KCl), and the 
apparent molecular mass of C25Mms6 is estimated to be 4.7 kD which means 
C25Mms6 has approximate 1.6 subunits in 1.5M KCl. Further increasing the 
salt concentration to 3 M KCl failed to change the multimeric state of 
C25Mms6. The apparent molecular mass C25Mms6 is estimated to be 4.3 kD 
in 3 M KCl (Fig. 15).  
The effect of pH on the multimeric state of C25Mms6 was also investigated 
by gel filtration chromatography (Fig. 16). At pH 10.5, the apparent molecular 
mass of C25Mms6 is estimated to be 9.9 kD (3.4 subunits) which is close to 
that in the low salt concentration (100 mM KCl). The attempt of estimating the 
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apparent molecular mass of C25Mms6 at pH 3 was unsuccessful. The peak of 
BSA became irregular which indicates that BSA has been hydrolyzed at pH 3. 
The hydrolysis of C25Mms6 was also observed: The peak of C25Mms6 came 
after B12 (MM 1355 Daltons) (Fig. 17). 
The possible reason that C25Mms6 is measured to a nonintegral number 
of subunits may be that under the above experiment conditions, C25Mm6 
forms a mixture of monomers and dimers that are not resolved on the 
Superdex G75 column. The basis of using gel filtration chromatography to 
estimate the apparent molecular mass of unknown protein is that the unknown 
protein has the same shape as the globular proteins used as standards. So, 
another possible reason may be that C25Mms6 forms non-globular structures 
which increases the error for the apparent molecular mass estimation.  
An interesting observation was made regarding the multimeric state of 
C25Mms6. When the first 4 amino acids (YAYM) were removed from 
C25Mms6, the resulting peptide (C21Mms6: KSRDIESAQSDEEVELRDALA) 
exhibited a larger apparent molecular mass than that of C25Mms6. C21Mms6 
was first identified as a contaminant of C25Mms6. Fig. 18A shows the elution 
profile of a particular batch of C25Mms6 from a Superdex G75 column in 20 
mM Tris-HCl, 100 mM KCl, pH 7.5. The elution profile exhibited two major 
peaks, one at 13.13 ml and the other at 14.73 ml. This batch of C25Mms6 
showed two different major bands on 15 % SDS-PAGE gel (Fig. 18B), one 
corresponds to the peak at 13.13 ml and the other is the peak at 14.73 ml. The 
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N-terminal sequence results indicated that the faction eluted at 14.73 ml is 
C25Mms6 and the fraction eluted at 13.13 ml is C21Mms6 (Fig. 18C).  This 
peptide missed the first 4 amino acids of C25Mms6 and was name as 
C21Mms6. By using the standard curve (Fig. 13B), the apparent molecular 
mass of C21Mms6 is estimated to be 19.1 kD which indicates that C21Mms6 
forms an octamer assuming C21Mms6 is a globular protein. The molecular 
mass of monomeric C21Mms6 is 2.4 kD. We speculate that the first four 
hydrophobic amino acids in C25Mms6 might prevent the further 
multimerization of C25Mms6 or that C21Mms6 and C25Mms6 multimerize by 
different types of interaction. 
The above results indicated that C25Mms6 contains the functional domain 
of full length Mms6 and can stimulate the formation of magnetite nanoparticles 
with defined uniform structures that are similar to those formed in bacteria. The 
gel filtration results indicate that C25Mms6 forms a tetramer in normal salt 
condition (100 mM KCl) and that electrostatic interactions contribute to the 
multimerization of C25Mms6 as demonstrated by the results of the apparent 
molecular mass estimation of C25Mms6 in high salt (1.5 M KCl and 3 M KCl) 
and high pH (pH 10.5). 
 
Monomeric Mms6 and its activity 
 Because His-Mms6 and C25Mms6 both form multimers and both can 
stimulate the formation of magnetite particles with defined uniform structures, it 
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is reasonable to speculate that Mms6 forms a negatively charged surface with 
many moieties for chelating iron and thus provides a surface or template for 
the growth of magnetite nanoparticles.  
 To test this hypothesis, we first expressed and purified GST-Mms6 
(glutathione transferase tagged Mms6) in E.coli (Fig. 19). Glutathione 
transferase tag has a molecular mass of 26 kD and the full length Mms6 has a 
molecular mass about 6 kD. Attaching such a huge tag to a small protein 
should disrupt the interactions between Mms6 subunits by steric hindrance 
resulting in a monomeric GST-Mms6. The multimeric state of GST-Mms6 was 
investigated by resolving GST-Mms6 on a Superdex G75 column run at a   
0.4 ml/min flow rate, 4°C in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 (Fig. 20). The 
apparent molecular mass of GST-Mms6 was estimated to be about 28.4 kD, 
which indicates that GST-Mms6 forms a monomer. The calculated molecular 
mass of GST-Mms6 is about 32 kD. The cloning, expression and purification of 
GST-Mms6 were done by Pierre Palo.  
 We synthesized magnetite nanoparticles in vitro in the presence of 
GST-Mms6 and examined the size and morphology of GST-Mms6 stimulated 
magnetite nanoparticles by TEM (Fig. 21). The TEM results showed that the 
size of the magnetite nanoparticles synthesized in the presence of GST-Mms6 
varies from 3 to 15 nm. The shapes of these particles were mainly round. 
Overall, the magnetite nanoparticles synthesized with GST-Mms6 lack 
uniformity and defined structure. 
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uniformity and defined structure. 
The gel filtration chromatography results and TEM results indicate that the 
monomeric GST-Mms6 failed to stimulate the synthesis of magnetite 
nanoparticles with defined uniform structure and morphology. Our results 
suggest that multimeric but not monomeric forms of Mms6 effectively promote 
the formation of nanoparticles with defined uniform structures.  
 
Quaternary structure of C25Mms6K39A;R41A;R55A  
The fact that the structures and morphologies of the magnetite 
nanoparticles synthesized with GST-Mms6 lack uniformity supports our 
speculation that the multimeric forms of Mms6 are required for its function. 
However, we cannot exclude the possibility that the functional domain of Mms6 
is actually folded inside the whole structure and not accessible to iron when 
Mms6 is expressed in the form of GST-Mms6. However, this possibility is 
made less likely by the observation that GST is active in the context of the 
GST-Mms fusion protein. 
The results of the above studies have also demonstrated that C25Mms6 
contains the functional domain of full length Mms6 and forms multimers. We 
chose to use a C25Mms6 mutant to further test the validity of our hypothesis.  
The gel filtration results of C25Mms6 in different salt concentration buffers 
indicated that electrostatic interactions between different subunits contribute to 
the multimerization of C25Mms6. We converted all three basic amino acids in 
42 
the C25Mms6 sequence (K39, R41 and R55) into alanines. By changing these 
basic amino acids into alanines, it was predicted that the C25Mms6 mutant 
(C25Mms6K39A;R41A;R55A) would form a monomer.  
Gel filtration chromatography was used to examine the multimeric state of 
C25Mms6K39A;R41A;R55A. Fig. 22A shows the elution profile of 
C25Mms6K39A;R41A;R55A in 20 mM Tris-HCl, 100 mM KCl, pH 7.5. 
Unexpectedly, C25Mms6K39A;R41A;R55A was eluted at 14.92 ml. The 
apparent molecular mass of C25Mms6K39A;R41A;R55A is estimated to be 
11.1 kD which corresponds to a tetrameric C25Mms6K39A;R41A;R55A 
assuming it is globular. The monomeric molecular mass of 
C25Mms6K39A;R41A;R55A is 2.7 kD.  
The result indicates that the substitution of basic amino acids to alanines 
does not change the multimeric state of C25Mms6. We speculated that the 
alanines we brought into the C25Mms6 sequence might increase the 
hydrophobicity of C25Mms6 and cause C25Mms6K39A;R41A;R55A to form 
multimers again. Fig. 23A shows the elution profile of 
C25Mms6K39A;R41A;R55A in 20 mM Tris-HCl, 1.5 M KCl, pH 7.5. The 
apparent molecular mass of C25Mms6K39A;R41A;R55A is estimated to be 
3.7 kD which means C25Mms6K39A;R41A;R55A has approximate 1.4 
subunits in 1.5M KCl. This result indicates that the multimerization of 
C25Mms6K39A;R41A;R55A may not be caused by hydrophobic interactions. 
We also investigated the multimeric states of C25Mms6 and 
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C25Mms6K39A;R41A;R55A in the presence of detergent.  Fig. 24 shows the 
elution profile of C25Mms6 and C25Mms6K39A;R41A;R55A in 20 mM 
Tris-HCl, 100 mM KCl, 0.05 % (w/v) Brij 35 (Sigma-Aldrich Corp., St. Louis, 
MO),  pH 7.5. The peaks of C25Mms6 and C25Mms6K39A;R41A;R55A 
appeared in the same elution volume and were in front of the peak of aprotinin 
(MM 6.5 kD). Brij-35 is a non-ionic detergent that is used for isolating 
membrane proteins. It has been reported that protein components can be 
extracted from the membrane of the Staphylococcus aureus L form by a 
solution containing 0.05 % (w/v) Brij-35 (Akashi, Ono et al. 1996). The fact that 
both C25Mms6 and its mutant (C25Mms6K39A;R41A;R55A) form multimers in 
detergent support the hypothesis that the interactions between the subunits of 
the C-terminus of Mms6 are not hydrophobic.  
We have also considered the possibility that C25Mms6 may not have any 
regular secondary structure so that it exhibits a larger apparent molecular 
mass than expected.  But this cannot explain the fact that C21Mms6 has 
larger apparent molecular mass than C25Mms6. The nature of the 
multimerization of the C-terminus of Mms6 seems to be more complicated than 
we expected and requires more investigation.  
 
Mechanism of Mms6 stimulated magnetite nanoparticle formation 
The above results demonstrated that Mms6 forms large complexes and 
the C-terminal domain is the functional domain of Mms6. The multimeric forms 
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may be required for Mms6 to effectively promote the synthesis of magnetite 
nanoparticles with defined uniform structure and morphology. Based on these 
observations, we proposed a possible mechanism of Mms6 stimulated 
magnetite nanoparticle formation (Fig. 25).  
Our proposed mechanism states that Mms6 is a magnetosome 
membrane-associated protein and Mms6 is seen to have two separate 
domains. The hydrophobic N-terminal domain, which contains a series of 
lysine and glycine residues, is proposed to be a membrane domain that 
locates Mms6 in the magnetosome membrane bilayer. The hydrophilic 
C-terminal domain, which contains a series of acidic and basic amino acids, is 
the functional domain of Mms6 and forms a negatively charged surface. The 
carboxyl groups of the acidic amino acids in this negatively charged surface 
together with the hydroxyl groups of other amino acids may serve as the 
template for iron binding and the formation of magnetite nanoparticles with 
defined uniform structure and morphology.  
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CONCLUSIONS AND FUTURE DIRECTIONS 
Our current data indicate that Mms6, a magnetosome 
membrane-associated protein, forms large multimeric complexes. The 
C-terminus of Mms6 contains the functional domain of this protein and exhibits 
multimeric forms under the experimental conditions we investigated. The basic 
and acidic amino acid residues in the C-terminus of Mms6 have strong 
electrostatic interactions and are involved in the multimerization of Mms6.  
The investigation of sizes and morphologies of magnetite nanoparticles 
synthesized in the presence of His-Mms6, GST-Mms6 and C25Mms6 
suggested that multimeric forms of Mms6 may be required for the successful 
synthesis of magnetite nanoparticles with defined uniform structures and 
morphologies. The attempt to make a monomeric C25Mms6 by changing the 
basic amino acid residues into alanines was unsuccessful. The complexity of 
the force involved in multimerization in C-terminus of Mms6 is unexpected and 
requires further investigation.  
Finally, based on the above observations and the experiment results, we 
have proposed a possible mechanism of Mms6-stimulated magnetite 
nanoparticle formation. We propose that the hydrophobic N-terminus of Mms6 
locates the protein in the magnetosome membrane and the hydrophilic 
C-terminus of Mms6 forms multimers and a highly negatively charged surface 
that serves as a template for the formation of magnetite nanoparticles with 
defined uniform structure and morphology. 
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Our current experimental data and proposed mechanism are just the 
beginning of the real understanding of the biomineralization process in 
magnetotactic bacteria. There are several critical questions that need to be 
addressed in the future for a thorough understanding of the mechanism and 
process of Mms6 stimulated formation of magnetite nanoparticles.  
First, the measurements of the sizes and morphologies of magnetite 
nanoparticles synthesized in the presence of different protein samples were 
not performed by blind analysis. We cannot exclude possible subjective bias 
when the images were taken. All the data regarding the sizes and 
morphologies of nanoparticles were just qualitative, obviously quantitative 
magnetic property measurements of the magnetite nanoparticles synthesized 
are required. 
Secondly, the evidence regarding the necessity of multimeric forms of 
Mms6 for successful synthesis of magnetite nanoparticles with defined uniform 
structure is weak. Although monomeric GST-Mms6 failed to stimulate the 
formation of magnetite nanoparticles, we cannot exclude the possibility that 
Mms6 is folded inside the GST-tag or tightly associated with the surface of 
GST which makes it unavailable to bind iron. The attempt of making a 
monomeric C-terminus of Mms6 by mutating the basic amino acids to alanines 
was unsuccessful. Thus the interactions between the subunits of the 
C-terminus of Mms6 and the role of the multimeric form of Mms6 in magnetite 
formation require more investigation.  
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 Previous studies have qualitatively demonstrated that Mms6 can tightly 
bind iron (Arakaki, Webb et al. 2003; T. Prozorov 2007). Quantitative data 
regarding the binding constant and stoichiometry of iron to Mms6 were not 
reported. Fe55 binding studies, isothermal titration calorimetry (ITC) and 
UV/visible difference spectra were used to investigate the iron binding 
stoichiometry and iron bind constants of Mms6. Stoichiometric iron-binding 
was not observed using any of these three methods. The experimental 
conditions need further optimization. We also need to address the question of 
which oxidative form of iron (ferric or ferrous iron) can be bound by Mms6. To 
test the binding activity of ferrous iron to Mms6, the measurements of iron 
binding activities of Mms6 or its C-terminus can be performed in the freshly 
prepared buffer containing ferrous ion under argon.  
 To understand the mechanism of Mms6 stimulated magnetite nanoparticle 
formation, it is critical to solve the structure of Mms6. Our data indicate that the 
full length Mms6 forms large complexes so it will be very difficult to solve either 
the crystal or NMR structures for Mms6. Because our data demonstrated that 
the C-terminus of Mms6 contains the functional domain of Mms6 and forms 
smaller complexes, it is reasonable to study the structures of the C-terminus of 
Mms6 by either X-ray crystallography or NMR and to compare the structures 
obtained with and without iron. The structural study will give us a better 
understanding of the function and structure relationship of Mms6 as well as the 
mechanism of magnetite nanoparticle formation. 
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FIGURES AND TABLES 
 
Figure 1 Expression and purification of His-Mms6. (A) Nucleotide 
sequence cloned from the Magnetospirillum magneticum AMB-1 genome 
including the primers used for PCR and the protein sequence of recombinant 
His-Mms6; (B) His-Mms6 purified by Talon metal affinity chromatography 
detected by 15 %SDS PAGE and Western Blot using an Anti-His antibody; 
(A,B: Data from Pierre Palo); (C) Mass spectrum of His-Mms6; (D) N-terminal 
amino acid sequencing result of His-Mms6. 
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Figure 2 Enterokinase cleavage of His-Mms6. (A) 15 % SDS-PAGE 
analysis of His-mms6 cleaved in 2 mM and 20 μM CaCl2 buffers with a       
1 U: 20 μg recombinant enterokinase to His-Mms6 ratio; (B) Mass spectrum of 
His-Mms6 treated with recombinant enterokinase for 24 hours; (C) Proposed 
sequences of segments identified by Mass spectrometry. 
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Figure 3 TEM images of particles synthesized with His-Mms6.TEM images 
of magnetite nanoparticles obtained by co-precipitation of FeCl2 and FeCl3   
(A) without protein; (B) with His-Mms6; (C) with ferritin; (D) with His-Lnc2; (E) 
with BSA. Scale bar: 200 nm. (Data from Tanya Prozorov, (T. Prozorov 2007) ). 
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Figure 4 Iron binding ability of His-Mms6 tested by filter assay. The data is 
a summary of two experiments. In each experiment each protein was tested at 
0.67 μM in triplicate and the average cpm of 55Fe bound by each protein is 
represented by a bar above the protein name with the standard deviations 
represented as error bars. The iron concentration used was 10 μM  
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Figure 5 Iron binding curve of His-Mms6. 55Fe was incubated at different 
concentration from 0 to 2 μM with a fixed amount of His-Mms6 (90 nM) in 
20mM Tris-HCl, 145 mM NaCl, 0.01 % BSA, 2 % glycerol, 10mM KCl, pH 7.0.  
The reaction volume was 0.1 ml. All data were the average of duplicate values. 
Inset shows the Scatchard plot used to calculate Kd of iron binding to 
His-Mms6. (Linear regression formula used to calculate Kd: y = -0.014 x + 
0.042) 
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Figure 6 Iron binding of His-Mms6 in 20 mM Tris-HCl, 100 mM KCl, pH 7.5 
measured by ITC. (A) Titration of 100 μM FeCl3 into 10 μM His-Mms6. Upper 
panel: raw data; Lower panel: data after background subtraction. (B) Titration 
of 100 μM FeCl3 into 10 μM transferrin. Upper panel: raw data; Lower panel: 
data after background subtraction. (C) Titration of 100 μM FeCl3 into buffer 
used as background. 
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Figure 7 UV-visible spectra of His-Mms6, transferrin and BSA. Protein 
samples were incubated with different concentrations of FeCl3 in 18 mM 
Tris-HCl, 140 mM NaCl, pH 7.0 for 30 minutes. The UV-visible spectra were 
recorded by a ND-100 Spectrophotometer. Cell path length is 1 mm. 
(A) 100 μM His-Mms6. From bottom to top, the Fe3+ concentrations are: 0, 10, 
30, 70, 100, 150, 200 μM. Inset shows the spectra from 350-600 nm.        
(B) 50 μM transferrin. From bottom to top, the Fe3+ concentrations are: 0, 10, 
20, 40, 50, 100, 150 μM. Inset shows the spectra from 350-600 nm. (C) 20 μM 
BSA. From bottom to top, the Fe3+ concentrations are: 0, 10, 20, 50, 100 μM. 
Inset shows the spectra from 300-750 nm. 
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Figure 8 Sedimentation velocity analysis. The sediment coefficient profile of 
0.46 mg/ml His-Mms6 in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,    
1.4 mM KH2PO4, pH 7.2. The sedimentation of His-Mms6 was monitored at 
280 nm, 30000 rpm, 4 oC for 2 hours.  
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Figure 9 Gel filtration chromatography of His-Mms6 under isotonic 
conditions. The elution profile of His-Mms6 from a Superose 12 column run at  
a 0.5 ml/min flow rate, 4 oC in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 
1.4 mM KH2PO4, pH 7.2. The sample injected was a 0.2 ml mixture of 1.2 
mg/ml His-Mms6 and 0.4 mg/ml B12. The elution profile of a 1 ml  mixture of 
1 mg/ml  Blue dextran (MM 2000 kD) and 0.1 mg/ml B12 (MM 1355 Daltons) 
in the same buffer as His-Mms6 was used for comparison 
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Figure 10 Gel filtration chromatography of His-mms6 under denaturing 
conditions. The elution profile of His-mms6 from a Superdex75 column run at 
a 0.4 ml/min flow rate, 4 oC in 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 
1.4 mM KH2PO4, 6 M GnCl, pH 7.2. The sample was 1 ml of 0.5 mg/ml 
His-Mms6. The elution profile of a 1 ml mixture of 5 mg/ml BSA (MM 65 kD) 
and 5 mg/ml ferritin (monomeric MM 20 kD) in the same buffer as His-Mms6 
was used for comparison. 
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Figure 11 Percent volume size distribution of His-Mms6 measured using 
dynamic light scattering (DLS). The sample measured was 0.5 mg/ml 
His-Mms6 in 137mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, 
pH 7.2. The measurements were performed at 25 oC. Each measurement 
consisted of a series of 11 acquisitions of 10 seconds each that was repeated 
3 times. The quantitative results presented here are the average of three 
measurements.  
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Figure 12 TEM images of particles synthesized with C25Mms6. TEM 
images of magnetite nanoparticles obtained by co-precipitation of FeCl2 and 
FeCl3 in the presence of C25Mms6 and His-Mms6 (Data from Tanya Prozorov). 
(A) With His-Mms6; (B) With C25Mms6 
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Figure 13 Apparent molecular mass estimation of C25Mms6 by gel 
filtration. C25Mms6 and the protein standards were resolved separately in 20 
mM Tris-HCl, 100 mM KCl, pH7.5 through a Superdex G75 column run at a  
0.4 ml/min flow rate, 4 oC. (A) The elution profile of C25Mms6. The sample  
was 0.5 ml of 0.2 mg/ml C25Mms6. (B) The standard curve used to estimate 
the apparent molecular mass of C25Mms6. Samples used to generate the 
standard curve were: 0.1 mg/ml BSA, 1 mg/ml carbonic anhydrase, 1 mg/ml 
ovalbumin,1 mg/ml myoglobin, 1 mg/ml aprotinin, 1 mg/ml Blue Dextran. The 
volume of each injection was 0.3 ml. (-◊- Data used for calculation; -Δ- 
C25Mms6; Linear regression formula used for MM estimation: 
Y=-1.20X+6.22). 
61 
 
 
 
 
 
 
 
 
 
 
Figure 14 Gel filtration chromatography of C25Mms6 in high salt (1.5 M 
KCl). C25Mms6 and the protein standards were resolved separately in      
20 mM Tris-HCl, 1.5 M KCl, pH 7.5 through a Superdex G75 column run at a 
0.4 ml/min flow rate, 4 oC. (A) The elution profile of C25Mms6. The sample 
was 0.2 ml of 0.1 mg/ml C25Mms6. (B) The standard curve used to estimate 
the apparent MM of C25Mms6. Samples used to generate the standard curve 
were: 0.1mg/ml BSA, 0.1mg/ml carbonic anhydrase, 0.1mg/ml 
ovalbumin,1mg/ml myoglobin, 0.5mg/ml aprotinin, 1mg/ml Blue Dextra and 0.1 
mg/ml B12 mixture. The volume of each injection was 0.2ml. (-◊- Data used for 
calculation; -Δ- C25Mms6; Linear regression formula used for MM estimation:  
Y= -1.46X + 6.60) 
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Figure 15 Gel filtration chromatography of C25Mms6 in high salt (3 M 
KCl). C25Mms6 and the protein standards were resolved separately in 20 mM 
Tris-HCl, 3 M KCl, pH 7.5 through a Superdex G75 column run at a 0.4 ml/min 
flow rate, 4 oC. (A) The elution profile of C25Mms6. The sample was 0.2 ml of 
0.1 mg/ml C25Mms6. (B) The standard curve used to estimate the apparent 
MM of C25Mms6. Samples used to generate the standard curve were: 0.1 
mg/ml BSA, 0.1 mg/ml carbonic anhydrase, 0.1 mg/ml ovalbumin, 1 mg/ml 
myoglobin, 0.5 mg/ml aprotinin, 1 mg/ml Blue Dextran and 0.1 mg/ml B12 
mixture. The volume of each injection was 0.2 ml. (-◊- Data used for calculation; 
-Δ- C25Mms6; Linear regression formula used for MM estimation:           
Y= -1.16X+6.18) 
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Figure 16 Apparent molecular mass estimation of C25Mms6 at pH 10.5. 
C25Mms6 and the protein standards were resolved separately in 0.1 M 
carbonate-bicarbonate buffer, pH10.5 through a Superdex G75 column run at 
a 0.4 ml/min flow rate, 25 oC. (A) The elution profile of C25Mms6. The sample 
was 0.2 ml of 0.1 mg/ml C25Mms6. (B) The standard curve used to estimate 
the apparent MM of C25Mms6. Samples used to generate the standard curve 
were: 0.1 mg/ml BSA, 0.1 mg/ml carbonic anhydrase, 0.1 mg/ml ovalbumin,1 
mg/ml myoglobin, 0.5 mg/ml aprotinin, 1 mg/ml Blue Dextran and 0.1 mg/ml 
B12 mixture. The volume of each injection was 0.2 ml. (-◊- Data used for 
calculation; -Δ- C25Mms6; Linear regression formula used for MM estimation: 
Y= -1.46X+6.53) 
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Figure 17 Gel filtration chromatogram of C25Mms6 at pH 3.The elution 
profile of C25Mms6 from a Superdex G75 column run at 0.4 ml/min flow rate,  
4 oC in 0.1 M sodium citrate, pH 3. The sample injected was 0.2 ml of       
0.1 mg/ml C25Mms6. The elution profile of a 1ml of 0.1mg/ml B12        
(MM 1355 Daltons) in 0.1 M sodium citrate, pH 3 was used for comparison.  
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Figure 18 Gel filtration chromatography of a mixture of C25Mms6 and 
C21Mms6. A preparation of C25 Mms6 was resolved through a Superdex G75 
column run at a 0.4 ml/min flow rate, 4 oC in 20 mM Tris-HCl, 100 mM KCl,  
pH 7.5. (A) The elution profile of a mixture of 0.2 mg/ml C25Mms6 and 
C21Mms6.  The volume injected was 0.1 ml. (B) Fractions of C25Mms6 and 
C21Mms6 resolved by Superdex G75 detected by 15% SDS-PAGE gel.  
Lane 1: Sample loaded on the column; Lane 2, 3, 4: Fractions at 13.13 ml. 
Lane 5, 6: Fractions at 14.73. (C) N-terminal amino acid sequence results of 
peaks at 13.13 ml and 14.73 ml. 
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Figure 19 Expression and purification of GST-Mms6 by 
Glutathione-Superflow chromatography. (A) GST-Mms6 protein was 
purified by Glutathione-Superflow chromatography and detected by 15% SDS 
PAGE. Lane 1: Protein Marker, Lane 2-7: Factions eluted with 10 mM 
glutathione, 50 mM Tris-HCl, pH 8.0. (B) Purified GST-Mms6 protein was 
detected by anti-GST antibodies. (Data from Pierre Palo).  
67 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 Apparent molecular mass estimation of GST-Mms6 by gel 
filtration chromatography. GST-Mms6 and the protein standards were 
resolved separately in 20mM Tris-HCl, 100mM KCl, pH 7.5 through a 
Superdex G75 column run at a 0.4 ml/min flow rate, 4 oC.(A) The elution profile 
of GST-Mms6. The sample was 1ml of 0.136 mg/ml GST-Mms6; (B) The 
standard curve used to estimate the apparent molecular mass of GST-Mms6. 
Samples used to generate the standard curve were: 0.1 mg/ml BSA, 1 mg/ml 
carbonic anhydrase, 1 mg/ml ovalbumin, 1 mg/ml myoglobin, 1 mg/ml aprotinin, 
1 mg/ml Blue Dextran (-◊- Data used for calculation; -Δ- GST-Mms6; Linear 
regression formula used for MM estimation:Y= -1.20X+6.22). 
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Figure 21 TEM images of particles synthesized with GST-Mms6. TEM 
images of magnetite nanoparticles obtained by co-precipitation of FeCl2 and 
FeCl3 in the presence of GST-Mms6 and GST (TEM imaging performed by 
Tanya Prozorov). (A) GST-Mms6; (B) With GST. 
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Figure 22 Apparent molecular mass estimation of C25Mms6 mutant by 
gel filtration. C25Mms6 mutant (C25Mms6K39AR41AR55A) and the protein 
standards were resolved separately in 20 mM Tris-HCl, 100 mM KCl, pH7.5 
through a Superdex G75 column run at a 0.4 ml/min flow rate, 4 oC. (A) The 
elution profile of C25Mms6K39AR41AR55A. The sample was 0.5 ml of     
0.2 mg/ml C25Mms6K39AR41AR55A; (B) The standard curve used to 
estimate the apparent molecular mass of C25Mms6K39AR41AR55A. Samples 
used to generate the standard curve were: 0.1 mg/ml BSA, 1 mg/ml carbonic 
anhydrase, 1 mg/ml ovalbumin, 1 mg/ml myoglobin, 1 mg/ml aprotinin, 1 mg/ml 
Blue Dextran. The volume of each injection was 0.3 ml. (-◊- Data used for 
calculation; -Δ- C25Mms6K39AR41AR55A; Linear regression formula used for 
MM estimation: Y=-1.20X+6.22)
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Figure 23 Gel filtration chromatography of C25Mms6 mutant in high salt 
(1.5 M KCl). C25Mms6 mutant (C25Mms6K39AR41AR55A) and the standard 
proteins were resolved separately in 20 mM Tris-HCl, 1.5 M KCl, pH 7.5 
through a Superdex G75 column run at a 0.4 ml/min flow rate, 4 oC. (A) The 
elution profile of C25Mms6K39AR41AR55A. The sample was 0.2 ml of 0.1 
mg/ml C25Mms6K39AR41AR55A. (B) The standard curve used to estimate 
the apparent MM of C25Mms6K39AR41AR55A. Samples used to generate the 
standard curve were: 0.1mg/ml BSA, 0.1mg/ml carbonic anhydrase, 0.1mg/ml 
ovalbumin,1mg/ml myoglobin, 0.5mg/ml aprotinin, 1mg/ml Blue Dextra and 0.1 
mg/ml B12 mixture. The volume of each injection was 0.2ml. (-◊- Data used for 
calculation; -Δ- C25Mms6K39AR41AR55A; Linear regression formula used for 
MM estimation: Y=-1.46X+6.59)  
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Figure 24 Gel filtration chromatogram of C25Mms6 and its mutant in 
detergent. C25Mms6 and its (C25Mms6K39AR41AR55A) were resolved 
separately in 20mM Tris-HCl, 100 mM KCl, 0.05 % Brij-35 (w/v), pH 7.5 
through a Superdex G75 column run at 0.4 ml/min flow rate, 25 oC. The 
sample injected was 0.5 ml of 0.5 mg/ml C25Mms and 0.5 ml of 0.5 mg/ml 
C25Mms6K39AR41AR55A. The elution profile of a 0.2ml of 0.1mg/ml aprotinin 
in 20mM Tris-HCl, 100 mM KCl, 0.05 % Brij-35 (w/v), pH 7.5 was used for 
comparison.   
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Figure 25 Proposed mechanism of Mms6 stimulated magnetite 
nanoparticle synthesis. Mms6 is seen to have two separate domains. The 
N-terminal domain is a membrane domain and locates Mms6 in the 
magnetosome membrane bilayer. The C-terminal domain is the functional 
domain of Mms6 and has multimeric forms serving as a template for magnetite 
nanoparticle synthesis. 
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Table 1. Summary of multimerization states of His-Mms6 and its 
C-terminal domains in different salt concentrations. 
 
1.5 1.6 4 7 
ND ND 8 13 
ND 1.4 4.2 ND 
C25Mms6 
C21Mms6 
C25Mms6K39A; 
R41A;R55A
ND ND ~20-40*** ND 
(10 mM)** 100 mM* 3 M* 1.5 M* 
His-Mms6 
KCl (mM) 
Number of subunits 
 
Samples were tested in the presence of KCl as indicated in the table with the 
following exceptions: *20 mM Tris-HCl, pH 7.5, **Na2HPO4, pH 7.5, ***137 mM 
NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM K2HPO4, pH 7.2 
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